Superior Planning LLC’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Other funds holding LGND
Superior Planning LLC's LGND Position: Q3 2026 in Review
Superior Planning LLC opened a new position in Ligand Pharmaceuticals (LGND) in Q3 2026: 75 shares worth $23.4K. The stake represents 0.01% of the portfolio and ranks #633 among its holdings.
366 funds tracked by Wall St. Rank hold LGND as of Q3 2026.
- Superior Planning LLC held 75 shares of Ligand Pharmaceuticals worth $23.4K as of Q3 2026.
- Ligand Pharmaceuticals was a new Superior Planning LLC position in Q3 2026.
- Ligand Pharmaceuticals made up 0.01% of Superior Planning LLC's portfolio in Q3 2026, its #633 holding.
- 366 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2026.
Based on Superior Planning LLC's 13F filing for Q3 2026, filed 12 Nov 2026.